Rubius Therapeutics, Inc. insider trading activity

Understanding Insider Activity at Rubius Therapeutics, Inc.

Welcome to our dedicated page for Rubius Therapeutics, Inc. (Nasdaq: RUBY) insider trading activity, sourced directly from the SEC Form 4 Filings. Here, you'll find the latest buying and selling activities undertaken by Rubius Therapeutics, Inc.'s key insiders, providing a unique window into the company's internal sentiments.

How to Use This Data:

Below, you can view insider transactions that were reported to the SEC within the last 365 days.

While insider trading can hint at a company's prospects, it's crucial to approach this data as part of a broader investment strategy. Look for patterns over time, significant buys or sells, and consider other market factors before making investment decisions.

Scroll down to view the most recent insider transactions for Rubius Therapeutics, Inc., and gain a better understanding of the confidence and considerations of those intimately tied to the company's success.

Track insider trades for RUBY
TickerTime & DateFilingLink
RUBY11:08:34 PM, 02/27/2023
Appelhans Dannielle(CEO and President) sold 10385 shares of Rubius Therapeutics, Inc. (RUBY) for ~$1350
Filing
RUBY02:41:05 AM, 02/02/2023
CAGNONI PABLO J sold 8448 shares of Rubius Therapeutics, Inc. (RUBY) for ~$2112
Filing
RUBY02:40:03 AM, 02/02/2023
Appelhans Dannielle(CEO and President) sold 3878 shares of Rubius Therapeutics, Inc. (RUBY) for ~$969
Filing
RUBY02:51:39 AM, 02/01/2023
CAGNONI PABLO J sold 7240 shares of Rubius Therapeutics, Inc. (RUBY) for ~$1737
Filing
RUBY02:50:16 AM, 02/01/2023
Turka Laurence A.(Chief Scientific Officer) sold 2593 shares of Rubius Therapeutics, Inc. (RUBY) for ~$622
Filing